Privium Fund Management B.V. / IONS
Privium Fund Management B.V.’s Ionis Pharmaceuticals Inc Position
Does Privium Fund Management B.V. own Ionis Pharmaceuticals Inc (IONS)? Yes — 290.0K shares worth $22M (+4.53% of its 13F portfolio) as of Q1 2026, up from 240.8K shares the prior filed quarter.
Position Value
$22M
Q1 2026
Shares
290.0K
% of Portfolio
+4.53%
Quarters Held
18
currently held
Position History IONS
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 290.0K | $22M | +4.53% |
| Q4 2025 | 240.8K | $19M | +3.51% |
| Q3 2025 | 248.9K | $16M | +2.93% |
| Q2 2025 | 267.6K | $11M | +2.31% |
| Q1 2025 | 267.6K | $8M | +2.10% |
| Q4 2024 | 266.8K | $9M | +2.11% |
| Q3 2024 | 250.7K | $10M | +2.50% |
| Q2 2024 | 247.3K | $11M | +2.85% |
| Q1 2024 | 227.0K | $10M | +2.63% |
| Q4 2023 | 217.5K | $11M | +3.20% |
| Q3 2023 | 228.5K | $10M | +3.08% |
| Q2 2023 | 226.5K | $9M | +2.68% |
| Q1 2023 | 182.8K | $7M | +2.19% |
| Q4 2022 | 148.8K | $6M | +2.11% |
| Q3 2022 | 148.8K | $7M | +2.39% |
| Q2 2022 | 180.1K | $7M | +2.21% |
| Q1 2022 | 180.1K | $7M | +1.47% |
| Q4 2021 | 630.2K | $19M | +3.82% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of IONS.